This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Epocrates App Is #1 Among U.S. Physicians, Again

WATERTOWN, Mass., May 1, 2013 (GLOBE NEWSWIRE) -- Epocrates remains the dominant medical application on physicians' mobile devices in 2013. Epocrates, Inc., an athenahealth (Nasdaq:ATHN) company, reigns as the digital health care leader in terms of app reach, according to the recently released Manhattan Research Taking the Pulse ® U.S. 2013 annual study of physicians' technology adoption and behavior.

Relevant findings from the Taking the Pulse U.S. study include:
  • Epocrates is the most popular medical application on both smartphone (70 percent) and tablet (50 percent) devices among U.S. physician app users
  • Thirty-four percent of physicians using Epocrates on a smartphone launch the app three or more times a day – a 20 percent growth rate since 2012
  • Drug references remain a primary digital resource accessed by physicians during and between patient consultations

"Epocrates is extraordinarily helpful for learning about new medications, potential adverse reactions, and checking for drug interactions on the spot," said Dr. Daniel Clearfield of Fort Worth, Texas. "I count on Epocrates for all of this critical content, as well to keep me abreast of new updates and guidelines with DocAlert messages."

"I haven't met a health care professional who doesn't know and love Epocrates," said Jonathan Bush, CEO and chairman, athenahealth. "We're ecstatic that Epocrates is part of the athenahealth family, and we are actively exploring ways to build on its incredibly powerful position in the hands of physicians on a daily basis. Epocrates is a constant in health care — repeatedly the top app on physicians' devices — that cannot be underrated when we look at the future of mHealth and the quantum leaps that will be made in connectivity and care coordination over the next few years."

About Epocrates, Inc.

Epocrates, Inc., an athenahealth company, is recognized for developing the #1 medical application among U.S. physicians for clinical content, practice tools, and health industry engagement at the point of care. Epocrates has established a loyal network of more than one million health care professionals, including 50 percent of U.S. physicians, who routinely use its intuitive solutions to help streamline workflow and improve patient care. For more information, please visit . Epocrates is a trademark of Epocrates, Inc., registered in the U.S. and other countries. About athenahealth, Inc.

athenahealth is a leading provider of cloud-based services for EHR, practice management, and care coordination. athenahealth's mission is to be caregivers' most trusted service, helping them do well doing the right thing. For more information, please visit or call 888-652-8200.
CONTACT: Holly Spring
         athenahealth, Inc. (Media)
         Dana Quattrochi
         athenahealth, Inc. (Investors)

athenahealth, Inc. logo

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.99 0.00%
FB $102.01 0.00%
GOOG $682.40 0.00%
TSLA $151.04 0.00%
YHOO $27.04 0.00%


Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs